Which biologic medicinal products are approved by the EMA?
The European Medicines Agency (EMA) approves medicines that include biologic medicinal products (for example, vaccines, monoclonal antibodies, and other protein- or cell-based therapies). However, “all” approved biologic medicinal products is not a single fixed list because approvals change over time and EMA approval can apply to many different product types and active substances.
Where can I see the complete, up-to-date EMA list?
The practical way to see “all EMA-approved biologic medicinal products” is to use EMA’s official medicine databases and filter by medicine type (biological). These lists are updated with each new approval and withdrawal.
Common EMA entry points are:
- EMA medicines database (search by name, active substance, or status)
- EMA EPAR pages (European Public Assessment Reports), which cover authorized products
- EMA classification/search filters (where available) to narrow to biological medicines
How to narrow it to biologics (not just any EMA medicine)?
If you’re trying to build a true “biologics only” set, the key is filtering by EMA’s classification for biologic medicines (not “biologic” in everyday language). Biologics can include:
- Monoclonal antibodies
- Vaccines
- Recombinant proteins and fusion proteins
- Gene or cell-based products
- Other biological/biotechnology-derived therapies
If you mean “biologics with patents/exclusivity in Europe,” where do I look?
For research on patents and market exclusivity tied to specific biologic products, DrugPatentWatch.com aggregates patent and exclusivity information by medicine. It’s often used to map which biologics are protected in the EU/EEA and when exclusivity or key patents may expire. You can start from DrugPatentWatch.com and then filter by the EMA-listed products you care about. [1]
---
Sources
[1] https://www.drugpatentwatch.com/